PFS
AYTU icon

Prospera Financial Services’s AYTU BioPharma AYTU Stock Holding History

Prospera Financial Services’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-25
Closed -$1K – 1687
2022
Q1 		$1K Buy
+25
New +$622 ﹤0.01% 2571
2020
Q4 		– Sell
-57
Closed -$14K – 745
2020
Q3 		$14K Buy
+57
New +$14.7K 0.01% 1000

Other funds holding AYTU

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Prospera Financial Services's AYTU Position: Q2 2022 in Review

Prospera Financial Services sold out of AYTU BioPharma (AYTU) in Q2 2022, closing a stake of 25 shares — an estimated $1K sold.

Prospera Financial Services first reported a position in AYTU in Q3 2020 and held it in 2 quarters. The position peaked at $14K in Q3 2020. 30 funds tracked by Wall St. Rank hold AYTU as of Q2 2022.

  • Prospera Financial Services reported no remaining AYTU BioPharma position as of Q2 2022 after selling out during the quarter.
  • Prospera Financial Services sold 25 AYTU BioPharma shares in Q2 2022, an estimated $1K.
  • Prospera Financial Services first reported a position in AYTU BioPharma in Q3 2020 and held it in 2 quarters.
  • Prospera Financial Services's AYTU BioPharma position peaked at $14K in Q3 2020.
  • 30 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2022.

Based on Prospera Financial Services's 13F filing for Q2 2022, filed 8 Aug 2022.